Plasmacytoid dendritic cells, IFN-alpha, Th-1 response
Plasmacytoid dendritic cells, IFN-alpha, Th-1 response
批准号:
6757906
负责人:
Frederick Paul Siegal
金额:
$20.61万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2006-06-30
关键词:
AIDSAIDS therapyHIV infectionsantiAIDS agentclinical researchcorticosteroidsdelayed hypersensitivitydendritic cellshelper T lymphocytehepatitis Ahepatitis vaccinehormone therapyhuman immunodeficiency virushuman subjecthumoral immunityimmunodeficiencyinterferon alphainterferon gammaleukocyte activation /transformationmicroorganism immunologypatient oriented researchprotein biosynthesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The proposed studies will address the hypothesis that a recently recognized cell type, the plasmacytoid dendritic cell (pDC), is an important participant in the production of cell-mediated (Th-1) immune responses in humans, pDC have been shown to be the principal producers of interferon (IFN)-alpha in the blood and tissues, and function as part of the innate immune system. It is believed that pDCs encounter microbial antigens in the periphery and migrate to secondary lymphoid organs, where they also influence naive T cells and other mononuclear cells in this microenvironment through the local production of IFN-alpha and other cytokines. This leads to a clonally selected, adaptive immune response characterized by the production of IFN-gamma and other cytokines that characterize the Th-1 response. To test the hypothesis, human subjects with either normal, reduced or undetectable numbers of circulating pDC will be immunized with a vaccine with which they have had no prior experience. Hepatitis A vaccine, an FDA-approved immunogen that is well tolerated and often clinically indicated in humans will be the vaccine of choice. The principal endpoint of the study will be the ability of the subjects' CD4+ T cells to generate IFN-gamma in vitro a month after receiving the immunization, compared to results at baseline. Numbers of CD4+ T cells, naive CD4+CD45RA+CD62L+ T cells, pDC number and function during the period of immunization, delayed-type hypersensitivity and serologic response to the immunogen, and clinical data will be monitored. Study subjects will include: healthy volunteers over a range of ages; patients with HIV infection being treated for severe immunodeficiency with active antiretroviral therapy; patients with HIV infection whose successful antiviral therapy is being stopped; patients with common, variable immunodeficiency; and patients or healthy volunteers undergoing courses of corticosteroids. In all these situations, there is a spectrum of pDC availability, while T cell numbers may be less affected. Our experience indicates that in some people in these categories, profound deficits of pDC number, IFN-alpha generation, or both will be present. Through the use of multivariate statistical analysis, the influence of functional, IFN-producing pDC on Th-1 immune responses will be defined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Plasmacytoid dendritic cells, IFN-alpha, Th-1 response
-
批准号:6589799
-
项目类别:
-
资助金额:$20.61万
-
财政年份:2003
-
负责人:Frederick Paul Siegal
-
依托单位:
AIDS: CHARACTERIZATION OF EARLY DEFECTS
-
批准号:3548599
-
项目类别:
-
资助金额:$27.3万
-
财政年份:1984
-
负责人:Frederick Paul Siegal
-
依托单位:
AIDS: CHARACTERIZATION OF EARLY DEFECTS
-
批准号:3548598
-
项目类别:
-
资助金额:$0.98万
-
财政年份:1984
-
负责人:Frederick Paul Siegal
-
依托单位:
海外基金